Lentigen Corporation is a biologic development and research company with headquarters based in Gaithersburg. Led by CEO Tim Ravenscroft, the company focuses primarily on the development and commercialization of breakthrough treatments for human disease. Through its technology platforms the company works to reprogram cells for use within the biotechnology and biomedicine industries, including for help in drug discovery, target validation, manufacturing, and cell therapies. Call for more information or to speak with an associate about services.